Skip to content
Disclosery

Alerce Investment Management, L.P.

Follow

13F filer, CIK 1844002, Chicago, IL

Alerce Investment Management, L.P. reported $75,152,551 across 5 holdings for the quarter ended 2023-12-31, in a 13F-HR filed 2024-02-09.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000895345-24-000038

Period
2023-12-31
Reported value
$75.2M
Holdings
5
Top 10 weight
100%
New
0
Sold out
1

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ANNXadded+350,000$1.59M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
ASSEMBLY BIOSCIENCES INCexited-2,227,500-$1.97M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2023

Share positions as resolved from 13F-HR 0000895345-24-000038, largest first. % of portfolio is the value over $75,152,551, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ANNXANNEXON INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 7,056,024 shares; 2023Q2: 7,056,024 shares; 2023Q3: 7,056,024 shares; 2023Q4: 7,406,024 shares 7,406,024$33.6M44.74%+350,000Timeline
AKBAAKEBIA THREAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 16,205,119 shares; 2023Q2: 16,205,119 shares; 2023Q3: 16,205,119 shares; 2023Q4: 16,205,119 shares 16,205,119$20.1M26.74%0Timeline
AMERICAN WELL CORPAMERICAN WELL CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 10,475,717 shares; 2023Q2: 10,475,717 shares; 2023Q3: 10,475,717 shares; 2023Q4: 10,475,717 shares 10,475,717$15.6M20.77%0
WHWKWHITEHAWK THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,630,830 shares; 2023Q2: 1,630,830 shares; 2023Q3: 1,630,830 shares; 2023Q4: 1,630,830 shares 1,630,830$3.29M4.38%0Timeline
RNTXREIN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 830,466 shares; 2023Q2: 830,466 shares; 2023Q3: 830,466 shares; 2023Q4: 830,466 shares 830,466$2.53M3.37%0Timeline

Sold out in Q4 2023

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
ASSEMBLY BIOSCIENCES INCASSEMBLY BIOSCIENCES INC2,227,500$1.97Mshares

How Q4 2023 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000895345-24-000038 base2024-02-09acceptance time not in the bulk data set